N-[3-[2-(dimethylamino)ethylcarbamoyl]-5-(trifluoromethyl)phenyl]-3-methyl-4-propylbenzamide
C23H28F3N3O2 — CID 165142642
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[2-(dimethylamino)ethylcarbamoyl]-5-(trifluoromethyl)phenyl]-3-methyl-4-propylbenzamide
N-[3-[2-(dimethylamino)ethylcarbamoyl]-5-(trifluoromethyl)phenyl]-3-methyl-4-propylbenzamide (PubChem CID 165142642) has the molecular formula C23H28F3N3O2 and a molecular weight of 435.49 g/mol. Its IUPAC name is N-[3-[2-(dimethylamino)ethylcarbamoyl]-5-(trifluoromethyl)phenyl]-3-methyl-4-propylbenzamide.
Molecular Properties
| Compound Name | N-[3-[2-(dimethylamino)ethylcarbamoyl]-5-(trifluoromethyl)phenyl]-3-methyl-4-propylbenzamide |
|---|---|
| PubChem CID | 165142642 |
| Molecular Formula | C23H28F3N3O2 |
| Molecular Weight | 435.49 g/mol |
| Exact Mass | 435.21 |
| IUPAC Name | N-[3-[2-(dimethylamino)ethylcarbamoyl]-5-(trifluoromethyl)phenyl]-3-methyl-4-propylbenzamide |
| SMILES | CCCc1ccc(C(=O)Nc2cc(C(=O)NCCN(C)C)cc(C(F)(F)F)c2)cc1C |
| InChI | InChI=1S/C23H28F3N3O2/c1-5-6-16-7-8-17(11-15(16)2)22(31)28-20-13-18(12-19(14-20)23(24,25)26)21(30)27-9-10-29(3)4/h7-8,11-14H,5-6,9-10H2,1-4H3,(H,27,30)(H,28,31) |
| InChIKey | SJEWAVRMCUFYRI-UHFFFAOYSA-N |
| XLogP | 4.51 |
| TPSA | 61.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.49 |
| LogP ≤ 5 | 4.51 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165142642 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.